Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05522972 · ClinicalTrials.gov registry record · NA
Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games
A NA study of Amblyopia, sponsored by Nova Southeastern University.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT05522972: Recruiting NA study of Amblyopia, sponsored by Nova Southeastern University.
NCT05522972 is a NA study of Amblyopia that is actively recruiting participants, run by Nova Southeastern University. The registered enrollment target is 180 participants, above the 158-participant average among 24 other Amblyopia trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05522972, a NA study of Amblyopia, is actively recruiting participants, sponsored by Nova Southeastern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. This study uses psychophysical measures to study neural plasticity in both adults and children with amblyopia.
Primary Outcome
"Visual acuity", the gold standard for vision testing, will be measured. Participants will be asked to read letters on a LogMAR letter chart. The smallest letters that can be read correspond to visual acuity (e.g., Snellen acuity of 20/20, letter-stroke width = 1 minute of arc).
Conditions Studied
Interventions
- BEHAVIORAL Video Game Vision Training
- BEHAVIORAL Perceptual Learning
- BEHAVIORAL Occlusion Therapy
Study Locations (1)
Florida
- Nova Southeastern University College of Optometry - Fort Lauderdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2022-09-13 |
| Est. Completion | 2029-08-31 |
| Phase | NA |
What NCT05522972 shows while recruiting
NCT05522972 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 158-participant average among 24 other Amblyopia trials with a reported enrollment target (14% higher).
The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 3 interventions - of which Video Game Vision Training is the first listed.
NCT05522972 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05522972 about?
NCT05522972 is a clinical study titled "Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games". Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. This study uses psychophysical measures to study neural plasticity in both adults and children with amblyopia.
What is the current status of trial NCT05522972?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2022-09-13. Estimated completion is 2029-08-31.
What conditions does trial NCT05522972 study?
This clinical trial studies the following conditions: Amblyopia.
What interventions are being tested in trial NCT05522972?
The interventions under investigation include: Video Game Vision Training (BEHAVIORAL), Perceptual Learning (BEHAVIORAL), Occlusion Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05522972?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05522972 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amblyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05522972's enrollment target sits among peer trials
180 9th of 24 higher than 16 of 24 other Amblyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amblyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Noninvasive Brain Stimulation in Adult Amblyopia
RECRUITING · NA
-
OCT Eccentric Fixation and Amblyopia in Children
RECRUITING · NA
-
Patch-free Occlusion Therapy
RECRUITING · NA
-
Amblyopia Treatment for Children Aged 8 to 12 Years
RECRUITING · NA
-
Novel Amblyopia Treatment With Virtual Reality Games
RECRUITING · NA
-
Binocular Amblyopia Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI